Market Positioning Solaris Diagnostics operates as a mid-sized, certified molecular diagnostics lab within the hospital and health care industry with annual revenue in the 25-50 million range and 51-200 employees. This suggests a solid client base and credibility to pursue broader hospital network partnerships and multi-site contracts.

Certification Advantage Full CLIA, CAP, and HIPAA certifications position Solaris as a trusted partner for regulated clinical testing. Use this to target healthcare systems and clinics prioritizing compliance-driven vendors for molecular diagnostics and episodic testing, including payer-facing labs.

Technology Fit Current tech stack includes lab and data integration tools (Cerner), which indicates compatibility with common EHR and health IT ecosystems. Leverage integration capabilities to propose seamless order-entry, data transfer, and reporting improvements for hospital networks already using Cerner.

Growth Opportunities Revenue range places Solaris between smaller specialized labs and larger national players. There is opportunity to upsell expanded panels, chronic disease molecular testing, and pharmacogenomics services to existing hospital clients and to win new mid-market accounts seeking scale without enterprise-level pricing.

Competitive Landscape Benchmark against peers of similar size and scope (e.g., Aperiomics, Invitae) to identify differentiators such as turnaround times, specialized panels, and research-backed testing. Position Solaris as a flexible, research-driven partner capable of rapid deployment for pilot programs and trials within hospital systems.